<DOC>
	<DOCNO>NCT00624026</DOCNO>
	<brief_summary>The study objective evaluate effect memantine treatment communication ability cognitive ability moderate severe DAT patient .</brief_summary>
	<brief_title>Memantine - Communication Study</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<criteria>Male female outpatient least 50 year age least 8 year education . The patient German mothertongue least speak language fluently order achieve similar score verbal task . Current diagnosis probable Alzheimer 's disease consistent NINCDS ADRDA criterion DSM IV TR criterion Dementia Alzheimer 's type . Mini Mental State Examination ( MMSE ) total score le 20 Patients treated acetylcholinesterase inhibitor ( AChEI ) may include , treatment start least 6 month prior screen stable last 3 month . Any type evident aphasia , may interfere patient 's communication difficulty cause Alzheimer 's disease History severe drug allergy , hypersensitivity , patient know hypersensitivity amantadine , lactose . Evidence ( include CT/MRI result ) clinically significant central nervous system disease Alzheimer 's disease . Modified Hachinski Ischemia score great 4 screening . Current evidence clinically significant systemic disease Known suspect history alcoholism drug abuse within past 10 year . Previous treatment memantine participation investigational study memantine .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>